Microbial biotechnology harnesses the diverse metabolic capabilities of microorganisms to develop innovative solutions with applications across various industries. By leveraging the metabolic pathways of bacteria, fungi, and algae, microbial biotechnologists engineer microorganisms to produce valuable compounds such as enzymes, biofuels, and pharmaceuticals. Through genetic manipulation and fermentation processes, microbial biotechnology enables the scalable production of bioproducts with high efficiency and sustainability. Furthermore, microbial biotechnologists explore the potential of microorganisms in bioremediation, utilizing their ability to degrade pollutants and detoxify contaminated environments. From improving agricultural productivity to advancing healthcare and environmental sustainability, microbial biotechnology holds promise for addressing complex challenges and driving economic growth through bio-based innovation.
 
                                 
                                 
                                 
                                 
                                 
                                 
                             
                             
                             
                            
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Mathematical modeling of COVID-19 dynamics in a West African context
Christabel Emaeyak James, University of Glasgow, United Kingdom
Title : Severe influenza and other related respiratory infection cases during Omicron era in Japan
Masafumi Seki, Saitama Medical University International Medical Center, Japan